Teladoc Health, Inc.·4

Jun 4, 4:07 PM ET

Geshuri Arnnon 4

4 · Teladoc Health, Inc. · Filed Jun 4, 2024

Insider Transaction Report

Form 4
Period: 2024-05-31
Geshuri Arnnon
Chief Human Resources Officer
Transactions
  • Sale

    Common Stock

    2024-06-03$11.16/sh1,807$20,16141,686 total
  • Exercise/Conversion

    Common Stock

    2024-05-31+1,17940,626 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-05-311,1793,538 total
    Common Stock (1,179 underlying)
  • Exercise/Conversion

    Common Stock

    2024-05-31+2,86743,493 total
  • Exercise/Conversion

    Common Stock

    2024-05-31+97739,447 total
  • Exercise/Conversion

    Performance Stock Units

    2024-05-319776,842 total
    Common Stock (977 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2024-05-312,86720,075 total
    Common Stock (2,867 underlying)
Footnotes (6)
  • [F1]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
  • [F2]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  • [F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
  • [F4]On March 1, 2024, the reporting person earned 11,728 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F5]On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F6]On March 3, 2023, the reporting person was granted 34,412 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Documents

1 file
  • 4
    wk-form4_1717531620.xmlPrimary

    FORM 4